In 2025, medical device manufacturers are grappling with heightened regulatory uncertainty, leading to slower reviews and communication difficulties with the FDA. This situation drives them to reassess operations for compliance and risk management, with a strong emphasis on maintaining product quality, which is vital for patient safety.
Why it Pays to Prioritize Quality Amid Regulatory Uncertainty
Related Posts
Starrett Automated Metrology and Force Measurement Inspection Solutions to be Demonstrated at The Quality Show
New Starrett AVR400 CNC Vision System to be featured at the show.
How to Ensure Your Robots Operate Safely
As robots gain prevalence in manufacturing, emphasizing their safe use is vital. This includes understanding safety features, challenges,…
Manufacturers Must Verify Products are Fit Through Analysis and Testing
This article highlights some key points of product hazard analysis.
